CSat Investment Advisory’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-88
Closed -$12K 1075
2020
Q3
$12K Buy
88
+11
+14% +$1.17K ﹤0.01% 1014
2020
Q2
$7K Buy
+77
New +$6.42K ﹤0.01% 1091

CSat Investment Advisory's MYOK Position: Q4 2020 in Review

CSat Investment Advisory sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 88 shares — an estimated $12K sold.

CSat Investment Advisory first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $12K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • CSat Investment Advisory reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 88 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $12K.
  • CSat Investment Advisory first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's MyoKardia, Inc. Common Stock position peaked at $12K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.